BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31046567)

  • 21. CDKL5 Deficiency Disorder Without Epilepsy.
    Aznar-Laín G; Fernández-Mayoralas DM; Caicoya AG; Rocamora R; Pérez-Jurado LA
    Pediatr Neurol; 2023 Jul; 144():84-89. PubMed ID: 37201242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDKL5 deficiency disorder and other infantile-onset genetic epilepsies.
    Daniels C; Greene C; Smith L; Pestana-Knight E; Demarest S; Zhang B; Benke TA; Poduri A; Olson HE;
    Dev Med Child Neurol; 2024 Apr; 66(4):456-468. PubMed ID: 37771170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The three stages of epilepsy in patients with CDKL5 mutations.
    Bahi-Buisson N; Kaminska A; Boddaert N; Rio M; Afenjar A; Gérard M; Giuliano F; Motte J; Héron D; Morel MA; Plouin P; Richelme C; des Portes V; Dulac O; Philippe C; Chiron C; Nabbout R; Bienvenu T
    Epilepsia; 2008 Jun; 49(6):1027-37. PubMed ID: 18266744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk.
    Oliver KL; Trivisano M; Mandelstam SA; De Dominicis A; Francis DI; Green TE; Muir AM; Chowdhary A; Hertzberg C; Goldhahn K; Metreau J; Prager C; Pinner J; Cardamone M; Myers KA; Leventer RJ; Lesca G; Bahlo M; Hildebrand MS; Mefford HC; Kaindl AM; Specchio N; Scheffer IE
    Epilepsia; 2023 May; 64(5):1351-1367. PubMed ID: 36779245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDKL5-associated developmental and epileptic encephalopathy: A long-term, longitudinal electroclinical study of 22 cases.
    Darra F; Monchelato M; Loos M; Juanes M; Bernardina BD; Valenzuela GR; Gallo A; Caraballo R
    Epilepsy Res; 2023 Feb; 190():107098. PubMed ID: 36739728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myoclonic encephalopathy in the CDKL5 gene mutation.
    Buoni S; Zannolli R; Colamaria V; Macucci F; di Bartolo RM; Corbini L; Orsi A; Zappella M; Hayek J
    Clin Neurophysiol; 2006 Jan; 117(1):223-7. PubMed ID: 16326141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Early-onset epileptic encephalopathy caused by CDKL5 mutation].
    Hjalmgrim H; Hansen LK; Ousager LB; Møller RS
    Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy.
    Neupauerová J; Štěrbová K; Vlčková M; Sebroňová V; Maříková T; Krůtová M; David S; Kršek P; Žaliová M; Seeman P; Laššuthová P
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):613-618. PubMed ID: 28872899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epileptic encephalopathy.
    Dulac O
    Epilepsia; 2001; 42 Suppl 3():23-6. PubMed ID: 11520318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder.
    Devinsky O; King L; Schwartz D; Conway E; Price D
    Epilepsia; 2021 Jul; 62(7):e98-e102. PubMed ID: 33979451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interictal spike quantification in continuous spike-wave of sleep (CSWS): Clinical usefulness of a wearable EEG device.
    Carvalho D; Mendes T; Dias AI; Leal A
    Epilepsy Behav; 2020 Mar; 104(Pt A):106902. PubMed ID: 31991392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant epileptic encephalopathies in children.
    Dulac OJ; Chiron C
    Baillieres Clin Neurol; 1996 Dec; 5(4):765-81. PubMed ID: 9068880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.
    Lim Z; Wong K; Olson HE; Bergin AM; Downs J; Leonard H
    Epilepsia; 2017 Aug; 58(8):1415-1422. PubMed ID: 28605011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epileptic encephalopathies of onset in neonates and infants].
    Guerrero Ruiz GDP
    Medicina (B Aires); 2022 Aug; 82 Suppl 3():13-18. PubMed ID: 36054851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encephalopathy with continuous spike-waves during slow-wave sleep: evolution and prognosis.
    Caraballo R; Pavlidis E; Nikanorova M; Loddenkemper T
    Epileptic Disord; 2019 Jun; 21(S1):15-21. PubMed ID: 31262717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of long-term neurocognitive functions in patients with epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS)/epileptic encephalopathy with spike-and-wave activation in sleep (EE-SWAS).
    Sager G; Takis G; Vatansever Pinar Z; Duzkalir H; Turkyilmaz A; Çağ Y; Akin Y
    Neurophysiol Clin; 2023 Feb; 53(1):102861. PubMed ID: 37058916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severity Assessment in CDKL5 Deficiency Disorder.
    Demarest S; Pestana-Knight EM; Olson HE; Downs J; Marsh ED; Kaufmann WE; Partridge CA; Leonard H; Gwadry-Sridhar F; Frame KE; Cross JH; Chin RFM; Parikh S; Panzer A; Weisenberg J; Utley K; Jaksha A; Amin S; Khwaja O; Devinsky O; Neul JL; Percy AK; Benke TA
    Pediatr Neurol; 2019 Aug; 97():38-42. PubMed ID: 31147226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ketogenic diet can be used successfully in combination with corticosteroids for epileptic encephalopathies.
    Ville D; Chiron C; Laschet J; Dulac O
    Epilepsy Behav; 2015 Jul; 48():61-5. PubMed ID: 26057351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate in childhood epileptic encephalopathy with continuous spike-waves during sleep: A retrospective study of 21 cases.
    Vrielynck P; Marique P; Ghariani S; Lienard F; de Borchgrave V; van Rijckevorsel K; Bonnier C
    Eur J Paediatr Neurol; 2017 Mar; 21(2):305-311. PubMed ID: 27641809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infantile epileptic encephalopathy with late-onset spasms: report of 19 patients.
    Auvin S; Lamblin MD; Pandit F; Vallée L; Bouvet-Mourcia A
    Epilepsia; 2010 Jul; 51(7):1290-6. PubMed ID: 20345938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.